Why isn’t treatment for depression leading to lower prevalence?

Population health guru Professor Tony Jorm asks why we’re not seeing sufferer numbers drop.

In this episode of Up Close podcast, public health researcher Professor Tony Jorm asks why prevalence of anxiety and depression in North America, Australia and elsewhere has not decreased despite a quarter century of more and better treatment for two of the world’s most common mental health problems.

Presented by Eric van Bemmel.

Although more people are getting treatment, it may not be very good treatment....we hypothesize there is actually a quality gap.

Full transcript and more information available here.

中国地区的听众可以通过此链接收听播客节目: http://upclose.unimelb.edu.au/episode/373-ongoing-symptoms-why-isn-t-treatment-depression-and-anxiety-leading-lower-prevalence

Prof Tony Jorm is a Professorial Fellow at the University of Melbourne and an NHMRC Senior Principal Research Fellow. His research focuses on building the community’s capacity for prevention and early intervention with mental disorders. Prof Jorm is the author of 27 books or monographs, over 500 journal articles and over 30 chapters in edited volumes. He has been awarded a Doctor of Science for his research and elected a Fellow of the Academy of Social Sciences in Australia. He is an Associate Editor of the Australian and New Zealand Journal of Psychiatry and a member of the Research Committee of Australian Rotary Health. He is a past President of the Australasian Society for Psychiatric Research. He has been listed in ISI HighlyCited.com as one of the most cited researchers in Psychology/Psychiatry of the past 20 years.

This article was first published on Pursuit. Read the original article.